This is to inform you that in pursuance to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Monday, 13th August, 2018 at Corporate Office and concluded just now has, inter-alia, transacted the following businesses: 1. Considered and Approved the UFR of the Company for the quarter ended 30th June, 2018. 2. Considered and taken on records Limited Review Report submitted by the Statutory Auditors of the company for the UFR for the quarter ended 30th June, 2018. 3. Reappointed M/s RMA & Associates as the Statutory Auditors of the Company for the further period of five years subject to the approval of shareholders in the forthcoming Annual General Meeting. Further pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, a copy of the aforesaid Financial Results for the quarter ended 30th June, 2018 alongwith Limited Review Report of the Statutory Auditors thereon are enclosed herewith for your kind perusal.
Pdf Link: Advik Laboratories Ltd. - Outcome Of The Board Meeting And Submission Of Unaudited Financial Results For The Quarter Ended 30Th June, 2018 As Required U/R 33 Of The SEBI (LODR) Regulations, 2015.
Source : BSE - www.bseindia.com